Fracture fixation in the operative management of hip fractures (FAITH): an international, multicentre, randomised controlled trial

Publication date

2017-04-15

Authors

Nauth, Aaron
Creek, Aaron T.
Zellar, Abby
Lawendy, Abdel Rahman
Dowrick, Adam
Gupta, Ajay
Dadi, Akhil
van Kampen, Albert
Yee, Albert
de Vries, Alexander C.

Editors

Advisors

Supervisors

Document Type

Article

Collections

License

Abstract

Background Reoperation rates are high after surgery for hip fractures. We investigated the effect of a sliding hip screw versus cancellous screws on the risk of reoperation and other key outcomes. Methods For this international, multicentre, allocation concealed randomised controlled trial, we enrolled patients aged 50 years or older with a low-energy hip fracture requiring fracture fixation from 81 clinical centres in eight countries. Patients were assigned by minimisation with a centralised computer system to receive a single large-diameter screw with a side-plate (sliding hip screw) or the present standard of care, multiple small-diameter cancellous screws. Surgeons and patients were not blinded but the data analyst, while doing the analyses, remained blinded to treatment groups. The primary outcome was hip reoperation within 24 months after initial surgery to promote fracture healing, relieve pain, treat infection, or improve function. Analyses followed the intention-to-treat principle. This study was registered with ClinicalTrials.gov, number NCT00761813. Findings Between March 3, 2008, and March 31, 2014, we randomly assigned 1108 patients to receive a sliding hip screw (n=557) or cancellous screws (n=551). Reoperations within 24 months did not differ by type of surgical fixation in those included in the primary analysis: 107 (20%) of 542 patients in the sliding hip screw group versus 117 (22%) of 537 patients in the cancellous screws group (hazard ratio [HR] 0·83, 95% CI 0·63–1·09; p=0·18). Avascular necrosis was more common in the sliding hip screw group than in the cancellous screws group (50 patients [9%] vs 28 patients [5%]; HR 1·91, 1·06–3·44; p=0·0319). However, no significant difference was found between the number of medically related adverse events between groups (p=0·82; appendix); these events included pulmonary embolism (two patients [<1%] vs four [1%] patients; p=0·41) and sepsis (seven [1%] vs six [1%]; p=0·79). Interpretation In terms of reoperation rates the sliding hip screw shows no advantage, but some groups of patients (smokers and those with displaced or base of neck fractures) might do better with a sliding hip screw than with cancellous screws. Funding National Institutes of Health, Canadian Institutes of Health Research, Stichting NutsOhra, Netherlands Organisation for Health Research and Development, Physicians' Services Incorporated.

Keywords

Aged, Aged, 80 and over, Bone Screws, Equipment Design, Female, Femoral Neck Fractures/surgery, Femur Head Necrosis/etiology, Fracture Fixation, Internal/adverse effects, Fracture Healing, Humans, Kaplan-Meier Estimate, Male, Quality of Life, Reoperation/statistics & numerical data, Single-Blind Method, Treatment Outcome, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Citation

Nauth, A, Creek, A T, Zellar, A, Lawendy, A R, Dowrick, A, Gupta, A, Dadi, A, van Kampen, A, Yee, A, de Vries, A C, de Mol van Otterloo, A, Garibaldi, A, Liew, A, McIntyre, A W, Prasad, A S, Romero, A W, Rangan, A, Oatt, A, Sanghavi, A, Foley, A L, Karlsten, A, Dolenc, A, Bucknill, A, Chia, A, Evans, A, Gong, A, Schmidt, A H, Marcantonio, A J, Jennings, A, Ward, A, Khanna, A, Rai, A, Smits, A B, Horan, A D, Brekke, A C, Flynn, A, Duraikannan, A, Stødle, A, van Vugt, A B, Luther, A, Zurcher, A W, Jain, A, Amundsen, A, Moaveni, A, van der Pol, C C, Meijer, J, van Wessem, K, Leenen, L P H, Simmermacher, R K J, Blokhuis, T J & Fixation using Alternative Implants for the Treatment of Hip fractures (FAITH) Investigators 2017, 'Fracture fixation in the operative management of hip fractures (FAITH) : an international, multicentre, randomised controlled trial', The Lancet, vol. 389, no. 10078, pp. 1519-1527. https://doi.org/10.1016/S0140-6736(17)30066-1